ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 1072 out of 5176

$332K Total Retail Price of All Prescriptions

Rank: 2092 out of 5176

658 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 7,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LISINOPRIL 443 407 1 5
HYDROCHLOROTHIAZIDE 390 370 2 10
SIMVASTATIN 367 351 3 1
ATENOLOL 329 316 4 12
ATORVASTATIN CALCIUM 310 302 5 9
LEVOTHYROXINE SODIUM 286 269 6 4
LOVASTATIN 259 226 7 46
OMEPRAZOLE 253 228 8 3
METFORMIN HCL 248 246 9 7
FUROSEMIDE 244 227 10 8
HYDROCODONE-ACETAMINOPHEN 190 156 S3 11 27
METOPROLOL SUCCINATE 153 147 12 11
SERTRALINE HCL 141 123 13 30
AMLODIPINE BESYLATE 135 134 14 2
ALENDRONATE SODIUM 134 117 15 18
DILTIAZEM 24HR ER 128 127 16 136
ISOSORBIDE MONONITRATE ER 123 101 17 44
METOPROLOL TARTRATE 116 114 18 6
DIOVAN 99 99 19 19
SPIRONOLACTONE-HCTZ 89 88 20 253
ENALAPRIL MALEATE 88 88 21 22
ALLOPURINOL 85 81 22 41
TRIAMTERENE-HCTZ 83 76 23 86
POTASSIUM CHLORIDE 80 73 24 34
CITALOPRAM HBR 71 67 25 31
RANITIDINE HCL 66 66 26 36
LOSARTAN POTASSIUM 65 55 27 14
FLUOXETINE HCL 63 51 28 132
DILTIAZEM 24HR CD 60 59 29 119
PROPRANOLOL HCL 57 57 30 199
KLOR-CON M20 53 38 31 129
MIRTAZAPINE 53 40 31 45
QUINAPRIL HCL 51 39 33 82
DONEPEZIL HCL 51 51 33 28
PRAVASTATIN SODIUM 50 40 35 23
SYMBICORT 50 46 35 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.